Uncategorized Why Eli Lilly closed its research center in China?

Why Eli Lilly closed its research center in China?

On September 7th, Eli Lilly, the US Pharma giant, closed its Zhangjiang research center in China, just a month after GlaxoSmithKline (GSK)’s ended its neuroscience unit in Shanghai. Andrew Hodge, the president and general manager of Lilly China, announced the news to the Chinese employees. He stressed that the move is slated to optimize the …

Read Article Read More